JP2025510311A5 - - Google Patents

Info

Publication number
JP2025510311A5
JP2025510311A5 JP2024557475A JP2024557475A JP2025510311A5 JP 2025510311 A5 JP2025510311 A5 JP 2025510311A5 JP 2024557475 A JP2024557475 A JP 2024557475A JP 2024557475 A JP2024557475 A JP 2024557475A JP 2025510311 A5 JP2025510311 A5 JP 2025510311A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
patient
compound
psoriasis
compound represented
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024557475A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025510311A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/016677 external-priority patent/WO2023192351A1/en
Publication of JP2025510311A publication Critical patent/JP2025510311A/ja
Publication of JP2025510311A5 publication Critical patent/JP2025510311A5/ja
Pending legal-status Critical Current

Links

JP2024557475A 2022-03-29 2023-03-29 Tyk2阻害剤およびその使用 Pending JP2025510311A (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US202263324754P 2022-03-29 2022-03-29
US63/324,754 2022-03-29
US202263344126P 2022-05-20 2022-05-20
US63/344,126 2022-05-20
US202263408572P 2022-09-21 2022-09-21
US63/408,572 2022-09-21
US202263429720P 2022-12-02 2022-12-02
US63/429,720 2022-12-02
PCT/US2023/016677 WO2023192351A1 (en) 2022-03-29 2023-03-29 Tyk2 inhibitors and uses thereof

Publications (2)

Publication Number Publication Date
JP2025510311A JP2025510311A (ja) 2025-04-14
JP2025510311A5 true JP2025510311A5 (https=) 2026-04-06

Family

ID=86142785

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024557475A Pending JP2025510311A (ja) 2022-03-29 2023-03-29 Tyk2阻害剤およびその使用

Country Status (11)

Country Link
US (1) US20250205211A1 (https=)
EP (1) EP4499092A1 (https=)
JP (1) JP2025510311A (https=)
KR (1) KR20240166011A (https=)
CN (1) CN119546299A (https=)
AU (1) AU2023245329A1 (https=)
CA (1) CA3246725A1 (https=)
IL (1) IL315866A (https=)
MX (1) MX2024011860A (https=)
TW (1) TW202342000A (https=)
WO (1) WO2023192351A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025064773A1 (en) * 2023-09-20 2025-03-27 Alumis Inc. Immediate-release formulations of a tyk2 inhibitor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7631193B2 (ja) 2018-10-22 2025-02-18 アルミス インコーポレイテッド Tyk2阻害剤およびその使用
AU2021254764A1 (en) * 2020-04-14 2022-11-03 Gossamer Bio Services, Inc. Substituted pyridines for the treatment of inflammatory diseases
WO2021237121A1 (en) * 2020-05-21 2021-11-25 Gossamer Bio Services, Inc. Substituted pyridines

Similar Documents

Publication Publication Date Title
JP5973411B2 (ja) 医薬組成物
RS64481B1 (sr) Lečenje alchajmerove bolesti kod posebne populacije pacijenata
JP2009513713A5 (https=)
JP2021502392A5 (https=)
JP2021500377A (ja) 遅延放出デフェリプロン錠剤及びその使用法
MX2024010637A (es) Nuevas combinaciones terapeuticas para el tratamiento de enfermedades pulmonares intersticiales fibrosantes progresivas.
CN102143687A (zh) 4-氨基吡啶在改善具有脱髓鞘和其它神经系统状况的患者的神经-认知和/或神经-精神病学损伤中的用途
JP2025510311A5 (https=)
JP6134064B2 (ja) ピペラジン化合物、及びドネペジルを含む認知障害関連疾病の予防用または治療用の薬学的組成物
EP2175850B1 (en) Treatment of anxiety
TWI783921B (zh) 手部溼疹之治療
US20120122919A1 (en) Pharmaceutical composition combining tenatoprazole and a histamine h2-receptor antagonist
MX2024006270A (es) Nueva composicion farmaceutica oral y regimen de dosificacion para la terapia de enfermedades pulmonares intersticiales fibrosantes progresivas.
CN117412751A (zh) 用于预防或治疗肺纤维化的药物制剂
JP2021066751A (ja) 経口用医薬組成物
WO2024129619A1 (en) Stat3 inhibitors for use in the treatment of non-viral liver cancer
WO2023066330A1 (zh) 依达拉奉在自闭症谱系障碍治疗中的应用
JP2024532129A5 (https=)
EP2184284B1 (en) Preventive, inhibitor or remedy for cerebral aneurysm comprising ibudilast as an active ingredient
JP2024543347A5 (https=)
JP6420923B1 (ja) 医薬
TW202408499A (zh) 降低血中肌肉生長抑制素之藥劑
JP2009501205A (ja) 精神病治療用組成物
JP2023543131A5 (https=)
TW202615042A (zh) 用於治療進行性纖維化間質性肺病之新穎治療組合